Absci (NASDAQ: ABSI)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-09-06 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.330 | -0.0400 | ||||
REV | 1.860M | 819.000K | -1.041M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Absci (NASDAQ: ABSI) through any online brokerage.
Other companies in Absci’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), Quanterix (NASDAQ:QTRX), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Absci (NASDAQ: ABSI) was reported by Stifel on Tuesday, May 31, 2022. The analyst firm set a price target for 10.00 expecting ABSI to rise to within 12 months (a possible 200.30% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Absci (NASDAQ: ABSI) is $3.33 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Absci.
Absci’s Q2 earnings are confirmed for Tuesday, September 6, 2022.
There is no upcoming split for Absci.
Absci is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.